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ABSTRACT: Carfentanil-xylazine (CX) has been the primary drug combination used for 
immobilizing free-ranging ungulates in Alaska, US, since 1986. We investigated the efficacy 
of a potential new drug of choice, thiafentanil (Investigational New Animal Drug A-3080). To 
determine effective doses for helicopter darting to immobilize free-ranging caribou calves 
(Rangifer tarandus granti) for radiocollaring, initial dosing trials were conducted on captive 
adult caribou. Captive trials indicated thiafentanil-azaperone-medetomidine could provide 
good levels of immobilization. However, field trials conducted in October 2013 on free-
ranging caribou calves found the combination too potent, causing three respiratory arrests and 
one mortality. The protocol was revised to thiafentanil-azaperone-xylazine (TAX), with good 
results. The induction time was not significantly different between the two combinations. 
However, the recovery time was significantly shorter for the TAX group than the CX group. 
A physiological evaluation was performed on 12 animals immobilized on CX and 15 animals 
on TAX. Arterial blood was collected after induction and again after 10 minutes of intranasal 
oxygen supplements (1 L/min).  Both groups had significant increases in PaO2 after oxygen 
treatment. There was a concurrent significant increase in PaCO2 in both groups. Rectal 
temperature increased significantly in both groups during the downtime, which is consistent 
with other studies of potent opioids in ungulates. Based on our results, we found TAX to be a 
potential alternative for the current CX protocol for immobilizing free-ranging caribou calves 
via helicopter darting.  
Key words: Anesthesia, carfentanil, caribou, hypoxemia, immobilization, opioid, 
thiafentanil.  
INTRODUCTION 
Caribou (Rangifer tarandus granti) have been chemically immobilized for management, 
translocations and research purposes in Alaska, US, since 1965 (Glenn 1967). Early 
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immobilizations were performed with neuromuscular blocking drugs (Bergerud et al. 1964; 
Glenn 1967), which were neither reliable nor safe. Etorphine in combination with 
acepromazine replaced the neuromuscular blocking drugs. However, etorphine was not 
readily available in a higher concentration than 1 mg/ml (Fong 1982; Valkenburg et al. 1983). 
When the potent opioid carfentanil was introduced to the market in 1986 at a concentration of 
3 mg/ml, it became the drug of choice for caribou immobilizations in Alaska. For the 
following 28 years, carfentanil in combination with the sedative xylazine has been the 
primary drug combination for free-ranging caribou immobilizations (Adams et al. 1988; 
Boertje et al.1996; Valkenburg 1997; Valkenburg et al. 1999).  
Ketamine in combination with medetomidine or xylazine is the drug of choice for 
rangifer immobilizations in Scandinavia and Canada (Arnemo et al. 2000; Arnemo and Aanes 
2009; Arnemo et al. 2011; Cattet 2011).This combination has been tested in Alaska caribou 
by one of the authors (K. B. B), but with longer than preferred induction and recovery times. 
Wildlife Pharmaceuticals Inc. (Windsor, Colorado, USA) and the Alaska Department 
of Fish and Game (ADF&G) collaborated to evaluate an alternative drug protocol and 
determine an effective dose for the Investigational New Animal Drug A-3080 (thiafentanil), 
in caribou. Thiafentanil has the potential to replace carfentanil as drug of choice for ungulate 
immobilizations. It has been used successfully in other wild ungulate immobilizations 
including moose (Alces alces) and elk (Cervus canadensis) (Stanley et al. 1988; McJames et 
al. 1994; Wolfe et al. 2004; Kreeger et al. 2005). Thiafentanil has a significantly shorter 
duration of action, and is less potent than carfentanil. Like carfentanil it is fast acting and fully 
reversible with the opioid antagonist naltrexone (Stanley and McJames 1986; Lance and 
Kenny 2011). Thiafentanil has a much higher therapeutic index than carfentanil and thus 
potentially offers a greater safety index for the human operator (Stanley and McJames 1986). 
Other studies have found that thiafentanil offers faster induction times than carfentanil and 
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etorphine, and a wide safety range in wild ungulates (Wolfe et al. 2004; Kreeger et al. 2005; 
Meyer et al. 2008). One of the authors (D. J. D.) found this in caribou as well.  
Azaperone is a tranquilizer with a wide safety range. Added to a drug combination 
including a potent opioid it is thought to improve respiration and decrease risk of 
hyperthermia (Meyer et al. 2008; Kreeger and Arnemo 2012). Azaperone also causes a certain 
degree of vasodilation, and can counteract the initial vasoconstriction caused by the alpha-2 
agonist (Meyer et al. 2008). Xylazine is an alpha-2 agonist providing sedation and muscle 
relaxation. Combined with thiafentanil and azaperone, xylazine is expected to improve muscle 
relaxation and ease handling of the immobilized animal. Medetomidine is another alpha-2 
agonist, more potent and selective for the alpha-2 agonist receptors than xylazine (Read 
2003). 
Potent opioids like carfentanil and thiafentanil are major respiratory depressants 
(Haigh 1990; Caulkett et al. 1994). Normally there is considerable capacity to increase the 
rate of oxygen supply and CO2 removal from the body tissues. However, during general 
anesthesia these adaptive systems are compromised. Anesthetized animals are incapable of 
regulating gas-exchange, increasing ventilation or cardiac output, and the spleen is often 
dilated and incapable of contracting to increase hemoglobin levels (McDonell and Kerr 2007). 
The result is hypoxemia; where the oxygenation of the blood is insufficient to meet the 
metabolic requirements, resulting in damage to vital organs (Caulkett et al. 1994). Severe 
hypoxemia has been documented in several immobilized wild cervids (Read et al. 2001; Read 
2003; Mich et al. 2008; Paterson et al. 2009; Risling et al. 2011; Evans et al. 2012; Fahlman et 
al. 2012; Evans et al., 2013; Lian et al. 2014). Subsequent adverse effects on behavior after 
chemical immobilizations have been documented in species like moose, polar bears (Ursus 
maritimus), grizzly bears (Ursus arctos), black bears (Ursus americanus) and mountain goats 
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(Oreamnus americanus) (Ramsay and Stirling 1986; Larsen and Gauthier 1989; Cotè et 
al.1998; Cattet et al. 2008).  
In this study the current carfentanil-xylazine protocol was compared to an alternative 
protocol using thiafentanil. To determine the appropriate dose for free-ranging caribou, an 
initial dose titration trial was conducted on captive caribou. In the free-ranging study a 
physiological evaluation of both the current carfentanil-xylazine protocol and the alternative 
protocol consisting of thiafentanil in combination with azaperone and an alpha-2 agonist was 
conducted.  
MATERIALS AND METHODS 
Study area and animals 
Fieldwork was conducted at four locations in Alaska during fall 2013 and spring 2014. 
Forty-five female caribou calves were immobilized for radiocollaring and weighing. Only 
animals successfully immobilized with a single dart were included in the study. In October 
2013, data were collected from 22 female calves from the Fortymile herd darted from a 
helicopter for radiocollaring in the Ladue River drainage in eastern Interior Alaska 
(63°30.70′N, 141°46.20′W), altitude 549–1,219 meters. In April 2014 data were collected 
from eight calves from the Mulchatna herd similarly darted and handled near Tundra Lake in 
southwest Alaska (61°13.50′N, 155°43.00′W), altitude 593 meters, and one from the 
Fortymile herd near Glacier Mountain in eastern Interior Alaska (64°42.40′N, 141°47.00′W), 
altitude 1,300 meters. In May 2014 data were collected from 14 Fortymile herd calves in the 
upper Charley River drainage in eastern Interior Alaska (64°51.40′N, 143°15.70′W), altitude 
1,000 meters. Calves were approximately 5 mo old in the fall captures and 11 mo old in the 
spring captures. The ambient temperature ranged from −7 C to 10 C.  
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Captive caribou trials were performed at University of Alaska Fairbanks Agricultural 
Research Station in Palmer Alaska in September 2013. Five yearlings were hand injected and 
two adults were darted with a CO2 powered rifle (Dan-Inject, Børkop, Denmark) with 
different drug combinations. 
All captures and handling methods were approved by ADF&G’s Division of Wildlife 
Conservation Institutional Animal Care and Use Committee (IACUC) protocol number 2013-
029F011. 
Drug combinations 
The carfentanil-xylazine (CX) drug combination for the fall captures (CX fall dose) 
was made by combining 1.5 mg carfentanil citrate (3 mg/ml, Zoopharm, Inc., Laramie, 
Wyoming, USA) and 20 mg xylazine (AnaSed
® 
100 mg/ml, Iowa, USA) in a 1 ml dart 
(Palmer Cap-Chur
®
, Powder Springs Georgia, USA). To account for heavier calves during the 
spring captures the carfentanil-xylazine dose was increased to 1.8 mg carfentanil and 25 mg 
xylazine (CX spring dose). The thiafentanil-azaperone-xylazine (TAX) drug combination was 
a mixture of 1.5 mg thiafentanil (10 mg/ml, Zoopharm, Inc.), 25 mg azaperone tartrate 
(50 mg/ml, Zoopharm, Inc.), and 20 mg xylazine in a 1 ml dart. The thiafentanil-azaperone-
medetomidine drug combination was made in two concentrations: TAMhigh and TAMlow. The 
TAMhigh dose was made by adding 1.5 mg thiafentanil, 25 mg azaperone and 5 mg 
medetomidine hydrochloride (20 mg/ml, Zoopharm Inc) to a 1 ml dart. The TAMlow dose was 
made in the same way but with 2 mg medetomidine. In some instances thiafentanil had 
crystallized in the vial. This was solved by heating the vial with hot water or by a lighter 
flame under the vial. All darts had a 19 mm barbed, end-ported needle. 
Female caribou calves were identified and darted from a Robinson R-44 helicopter 
(Robinson Helicopter Company, Torrance, California, USA) using a 22 caliber cartridge-fired 
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or CO2 powered remote delivery system (Palmer Cap-Chur
®
 pistol or Pneu-Dart
® 
rifle, 
Williamsport, Pennsylvania, USA) in epaxial or gluteal muscles from a distance of 5 - 10 
meters. After handling procedures were completed carfentanil was antagonized with 100 mg 
naltrexone hydrochloride (50 mg/ml, Zoopharm Inc) per 1 mg carfentanil. Xylazine was 
antagonized with 2 mg tolazoline hydrochloride (200 mg/ml Zoopharm Inc) per kg body 
weight. Thiafentanil was antagonized with 33 mg naltrexone/1 mg thiafentanil. Medetomidine 
was antagonized with atipamezole (20 mg/ml, Zoopharm Inc), in a relationship of 5 mg 
atipamezole for every 1 mg of medetomidine. This resulted in 150 mg naltrexone to 
antagonize 1.5 mg of carfentanil and 180 mg naltrexone to antagonize 1.8 mg of carfentanil. 
Fifty-milligram naltrexone was used to antagonize thiafentanil. Tolazoline at a dose of 100 – 
200 mg was used to antagonize xylazine and 25 mg atipamezole was used to antagonize 5 mg 
of medetomidine, whereas 10 mg atipamezole was used to antagonize 2 mg of medetomidine. 
The antagonists were administered intramuscularly (IM) in brachial or femoral muscle 
groups. For caribou recumbent with head on the ground at approach, tolazoline was 
administered immediately after the first arterial sample to achieve similar level of 
immobilization in all animals. Three emergencies required immediate intervention including 
intravenous (IV) administration of antagonists into the cephalic vein. For respiratory 
emergencies, doxapram (Dopram Injection 20 mg/ml, New Jersey, USA) was administered at 
a dose of 100 mg (5 ml) IV.  
Twenty-one calves from the Fortymile herd were immobilized with the CX 
combination. Six were immobilized with the CX fall dose and 15 were immobilized with the 
CX spring dose. . Nineteen calves were immobilized with the TAX combination. Out of these 
11 were immobilized in the fall from the Fortymile herd and eight were immobilized in the 
spring from the Mulchatna herd. Two calves were immobilized with the TAMhigh dose and 
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three were immobilized with the TAMlow dose. These five caribou were all from the fall 
captures in the Fortymile herd. The TAX dose was the same for both fall and spring captures. 
Captive caribou were immobilized with one of the following combinations: 
thiafentanil-medetomidine, thiafentanil-azaperone or thiafentanil-azaperone-medetomidine. 
Before the immobilization, all animals were weighed on a chute scale. Five yearlings were 
manually restrained for hand injection with an 18-gauge, 40 mm needle. Two adults were 
darted with a CO2 powered dart rifle (Dan-Inject, Børkop, Denmark). Antagonists were the 
same as for the free-ranging animals.  
Physiological evaluation and oxygen treatment 
Variables recorded for the free-ranging animals included time from darting to 
recumbency (induction time), time from recumbency to approach and handling the animal 
(capture time), time from darting until antagonists were administered (handling time) and time 
from administration of antagonist to standing (recovery time). These variables are 
summarized in Table 1. For both captive and free-ranging animals induction and recovery 
quality were assessed subjectively. Caribou found in lateral recumbency at approach, were 
placed in sternal recumbency. For those with head on the ground, snow was cleared around 
the nostrils. Pulse rate was measured by palpation of the auricular artery, respiration rate by 
counting thoracic elevations and rectal temperature with a digital thermometer. All variables 
were measured when the animal was first approached after recumbency, and repeated 10 
minutes later. 
Degree of central nervous system (CNS) depression was classified as level I (mildly 
affected, voluntary movement and intact reflexes), level II (no voluntary movement and intact 
reflexes), level III (unconsciousness, depressed reflexes, muscular relaxation) and level IV 
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(ceased respiration, dilated pupils). This evaluation was assessed at approach, and again 10 
minutes later. 
As soon as possible after approach and again 10 minutes after start of intranasal 
oxygen supplement an arterial blood sample was collected anaerobically from the auricular 
artery, using a pre-heparinized (Heparin Sodium Injection, USP 1,000 USP units/ml) 1 ml 
slip-tip syringe (Tuberculin Slip Tip Syringe, New Jersey, USA) and a 23-gauge needle. The 
blood sample was analyzed immediately using an i-STAT
®
1 Portable Clinical Analyzer and i-
STAT
®
 CG4+ cartridges (Abbott Laboratories, Illinois, USA). The analyzer was kept in an 
insulated box with warm water bottles to keep it at optimum temperature (16 - 30 C). 
Measured variables included pH, partial pressure of arterial oxygen (PaO2), partial 
pressure of arterial carbon dioxide (PaCO2) and lactate. PaO2, PaCO2 and pH were corrected 
based on rectal temperature. Calculated values included bicarbonate (HCO3
-
), hemoglobin 
oxygen saturation (SaO2), and base excess (BE). 
All animals were administered intranasal oxygen insufflation from a portable oxygen 
cylinder at a flow rate of 1 L/min (all free-ranging animals and four captive animals) or 2 
L/min (three of the captive animals). The oxygen nasal line was inserted 10 cm into one 
nostril and fixed with a clothes pin or tape. Venous blood samples for serum biochemistry 
were collected from the jugular or the cephalic vein. 
Hypoxemia was defined as mild (60 – 79 mmHg), marked (40 – 59 mmHg), or severe 
(< 40 mmHg). Hypercapnia was defined as mild (45 – 59 mmHg), marked (60 -79 mmHg) or 
severe (> 80 mmHg) (McDonnell and Kerr 2007). 
Statistical analysis 
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All statistical analyses were performed with linear models in statistical software R, 
version 3.1.1 (R Development Core Team 2014). Variables analyzed included rectal 
temperature, lactate, pH, PaO2, PaCO2, induction time and recovery time. All variables were 
tested for normal distribution using a histogram, and the assumptions for normality were 
fulfilled. For both drug combinations, the difference between the first and second sample was 
analysed using a two-tailed paired t-test. An ANOVA was used to compare variables 
(induction time, recovery time and rectal temperature change) from the two drug 
combinations. P values less than 0.05 were considered significant. Mean±SE (range) values 
are presented.  
RESULTS 
The CX combination was used to immobilize 21 calves. One calf darted with CX 
required an additional dart. Induction times and immobilization levels did not differ between 
CX fall and CX spring dose, and data for these animals were therefore pooled. The TAX 
combination was used to immobilize 19 calves. Two calves required one additional dart to 
complete induction. These two calves were excluded from further analysis. All inductions 
induced with a single dart were assessed as fast and smooth inductions. There were no 
differences in induction times between the CX and TAX combinations (F1,38 = 1.46, P = 0.23) 
(Fig. 1), however the recovery time was significantly (F1,38 = 14.49, P = <0.001) faster for the 
TAX group (Fig. 2). Induction times and recovery times for the TAX and CX groups are 
presented in Table 1.  
Degree of CNS depression was assessed to be level I for 18 calves and level II for one 
calf immobilized with TAX. None of the animals in the TAX group needed early antagonism 
of xylazine. The same evaluation was done for nine calves immobilized on CX, where four 
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calves were level I, one calf was level II and four calves were level III. Seven out of 21 
animals had xylazine antagonized early in the CX group. 
Blood gases were collected from 12 animals in the CX group and 15 animals in the 
TAX group. All calves were hypoxemic in the first blood gas measurement. In the CX group 
two calves were mildly hypoxemic, five calves were markedly hypoxemic and four calves 
were severely hypoxemic. One calf did not get a PaO2 reading. In the TAX group three calves 
were mildly hypoxemic, eight calves were markedly hypoxemic and four calves were severely 
hypoxemic before oxygen treatment. There was no difference (F1,25 >0.001, P = 0.99) 
between the groups  in arterial oxygenation in the first sample. Both groups had a significant 
(T1,25 = -9.68, P < 0.001) increase in PaO2 after oxygen treatment. 
 All calves, but two, were hypercapnic in the first blood gas 
measurement. In the CX group four calves were mildly hypercapnic and five calves were 
markedly hypercapnic. One calf was not hypercapnic and one calf did not get a PaCO2 
reading. In the TAX group seven calves were mildly hypercapnic and six calves were 
markedly hypercapnic. One calf was not hypercapnic and one calf did not get a PaCO2 
reading. There was no difference (F1,24 = 0.06, P = 0.85) in PaCO2 between the groups in the 
first arterial sample. Both the CX group (T1,10  = -2,555, P = 0.029) and the TAX group (T1,13 
= -2.642, P = 0.020) had a significant increase in PaCO2 after oxygen treatment .  
 
Lactate data was pooled for all caribou, as chase time is a confounding variable. Chase 
time was not collected consistently, and therefore not used as a variable. All animals had 
increased lactate in the first sample, with a value of 9.5±5.0 (1.1 - 19.5). All animals had a 
significant (T1,25 = 4.793, P = <0.001) decrease in lactate between samples. 
14 
 
Rectal temperature is also confounded by chase time. However, both the CX group 
(T1,20 = -3.875,  P < 0.001) and the TAX group (T1,18 = -2.7, P = 0.004) had a significant 
increase in rectal temperature during downtime (Fig. 3). The increase did not differ between 
the two treatments (F1,38= 1.83, P = 0.18). 
All physiological variables from the CX group are presented in Table 2 and from the 
TAX group in Table 3. 
 
The TAMhigh dose was used in two captures. The first calf was dead at approach. The 
other calf was not breathing at approach. This calf was successfully resuscitated by immediate 
intravenous administration of doxapram, naltrexone and atipamezole. It was also stimulated 
by twisting of nose and ears, and fierce rubbing of the back.  
The TAMlow dose was used on three captures. Degree of central nervous system 
depression was assessed to be level III, and medetomidine was antagonized immediately at 
approach. One calf stopped breathing after 5 minutes of handling time, but was also 
successfully resuscitated. Following these five captures, both TAM combinations were 
discontinued. All doses and physiological variables from TAMhigh, TAMlow and captive 
animals are presented in Table 4. 
All caribou were considered healthy, based on results from serum chemistry. 
Radio tracking 2 weeks post capture detected two mortalities in the CX group and two 
mortalities in the TAX group. One of the mortalities in the TAX group was found eaten by 
lynx 5 days post capture. Carcasses from these mortalities were not available for necropsy. 
All mortalities are considered capture related.  A field necropsy was performed on the carcass 
from the mortality with TAMhigh. Histopathology confirmed aspiration pneumonia as cause of 
death.  
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DISCUSSION 
This study documented use of thiafentanil-azaperone-xylazine and carfentanil-xylazine in 
free-ranging caribou. Further, blood gas values describing severe hypoxemia, which was 
easily resolved with intranasal oxygen, was documented. 
TAX immobilizations were characterized by caribou remaining sternal, head upright, 
relaxed, spontaneous palpebral reflex, and with a minor responsiveness to tactile stimulation. 
All calves, but one, were in the desired level I of CNS depression, and therefore did not need 
early antagonism of xylazine. Correct positioning and head holding behavior is important 
when immobilizing ruminants to prevent bloat and aspiration pneumonia (Kreeger and 
Arnemo, 2012). In the CX group caribou generally seemed to be in a deeper level (level II – 
III) of CNS depression. This assessment was only performed on nine animals, but seven out 
of 21 animals were antagonized early with tolazoline in this group. In contrast with findings 
in other studies (Kreeger et al. 2005; Meyer et al. 2008), TAX did not offer faster induction 
times than CX. However, the recovery time was significantly shorter for the TAX group than 
the CX group. This has also been documented in Shiras moose (Kreeger et al. 2005) and 
pronghorn antelope (Antilocapra americana) (Kreeger et al. 2001). These observed 
differences between carfentanil and thiafentanil are probably related to individual 
pharmacological potency.   
In conscious and healthy animals, the partial pressure of arterial oxygenation (PaO2) is 
expected to be between 80 and 100 mmHg (Steffey 2001; Fahlman 2014). In this study both 
groups were hypoxemic before oxygen supplement with a mean PaO2 value of 46 mmHg, 
which borderlines severe hypoxemia. This was not unexpected, based on results from 
previous blood gas studies on reindeers immobilized with other drug combinations (Risling et 
al. 2011; Fahlman et al. 2012; Evans et al. 2013). Hypoxemia leads to hypoxia which can 
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have devastating results with tissue necrosis on vital tissues including brain, heart, kidneys 
and liver, ending in organ failure (Caulkett et al. 1994; Fahlman 2014). Morbidity from 
hypoxia has been a neglected area in wildlife anesthesia. However, there are a few 
documented effects of behavior change after chemical immobilizations (Ramsay and Stirling 
1986; Cattet et al. 2008; Rode et al. 2014). Mountain goats were found to be more likely to 
abandon their kids after chemical immobilization than with physical immobilization (Cotè et 
al. 1998). Moose that had been chemically immobilized were found to have lower calf 
survival during a November moose census compared with moose that had not been 
chemically immobilized (Larsen and Gauthier 1989). Hypoxia affects all vital organs, but the 
cerebral cortex is especially vulnerable, and changes in cerebral function are recognized as an 
early sign of hypoxia in humans (Steffey 2001). The hypoxemia documented in this study was 
resolved with intranasal oxygen supplement. 
The increase in PaCO2 documented in this study was not unexpected, as it is a known 
side effect of both oxygen therapy and opioid induced hypoventilation (Schumacher et al. 
1997; Paterson et al. 2009; Risling et al. 2011; Evans et al. 2013; Lian et al. 2014). 
Ventilation is mainly controlled by central chemoreceptors in the medulla sensitive to pH and 
PaCO2 and peripheral chemoreceptors in the aortic and carotid bodies sensitive to pH and 
PaO2. During chemical immobilization the chemo receptors are depressed by opioids and 
sedatives, resulting in hypoventilation. Prolonged hypercapnia can lead to direct depression of 
cardiac contractility and a depressant effect on myogenic activity in the vascular system 
(Steffey 2001; McDonell and Kerr, 2007). To minimize hypercapnia it is important to keep 
oxygen flow rates minimal, and perform oxygen titration studies for new species receiving 
oxygen. Other measures against hypercapnia is short handling times, or endotracheal 
intubation and intermittent positive-pressure ventilation for longer handling operations 
(Hartsfield; 2007).  
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Both groups had a significant decrease in lactate between samples. The excitement and 
helicopter pursuit leads to an increased production of lactic acid in skeletal muscles. Lactic 
acid acidifies the blood, with a subsequent metabolic acidosis (Haga et al. 2009). Hypoxemia 
and subsequent muscle hypoxia can also produce lactic acid resulting in metabolic acidosis. 
Even though muscle tissue is one of the more robust tissues, the severe PaO2 values found in 
this study may have contributed to the high lactate levels (Steffey 2001; McDonell and Kerr 
2007). Similar values have been documented in chemically immobilized wild reindeer and 
moose, which also had a significant decrease during handling time (Haga et al. 2009; Evans et 
al. 2012; Evans et al. 2013; Lian et al. 2014). 
 
The normal body temperature in resting reindeer is 38.1-38.6 C (Blix et al. 2011). 
With helicopter pursuit, even though kept short, body temperatures are expected to increase 
due to the physical strain. Additionally, the anesthetic drugs interfere with the animal’s 
thermoregulation (Harthoorn and Walt 1974; Evans et al. 2013; Ko and Krimins 2014). In our 
study hyperthermia was present in both groups with mean values >40 C. Capture related 
hyperthermia is not uncommon, especially in rangifer, a species adapted to an arctic climate 
(Blix et al. 2011; Evans et al., 2013). Both treatment groups had a significant increase in 
temperature during handling time. This can possibly be descriptive of a temperature that will 
keep increasing post recovery, as described in other ungulate species immobilized with potent 
opioids (Meyer et al. 2008). There was a trend of higher increase in the CX group than the 
TAX group, which can be related to different pharmacological potency. 
The TAM combination was not an acceptable drug combination for free-ranging 
caribou calves at the doses tested. The combination resulted in one mortality and two 
respiratory arrests. Medetomidine is a potent alpha-2 agonist, with side effects including 
respiratory depression, aspiration pneumonia and decreased gastrointestinal motility. These 
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side effects are reinforced in combination with a potent opioid (Haigh 1990; Read 2003). The 
mortality with TAMhigh was due to aspiration pneumonia, most likely a direct cause of the 
high medetomidine dose.  
This study found TAX to be an efficient drug combination for free-ranging caribou 
calves. The doses tested in this study can be used as an alternative to the current CX 
combination. Thiafentanil should not be used in combination with medetomidine for 
immobilizing free-ranging caribou calves. The study also documented severe hypoxemia with 
both drug combinations. Hypoxemia was resolved with intranasal oxygen at a flow rate of 1 
L/min. For chemical immobilizations, we recommend keeping handling times to a minimum 
and using intranasal oxygen supplement. More research is needed on long term effects from 
chemical immobilizations that have been conducted without oxygen supplement.  
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Table 1. time from darting to recumbency (induction time), time from recumbency to approach and handling the 
animal (capture time), time from darting until antagonists were administered (handling time) and time from 
administration of antagonist to standing (recovery time) in free-ranging caribou (Rangifer tarandus granti) 
darted from helicopter with carfentanil-xylazine (CX) or thiafentanil-azaperone-xylazine (TAX) during fall 2013 
and spring 2014 in Alaska, USA. Mean ± SE (range) values are presented. 
Variable Units CX TAX 
    
Induction time Minutes 3.2±1.4 (1.5 - 7.0) 3.6±1.6 (2.0 - 7.5) 
Capture time Minutes 1.9±2.2 (0.25 - 5.0) 2.8±1.3 (2 - 5) 
Handling time Minutes 31.0±5.6 (21 - 40) 31.6±5.1 (26 - 44) 
Recovery time Seconds 220±85 (120 - 420) 133±67 (60 - 375) 
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Table 2.  Physiological variables from free-ranging caribou (Rangifer tarandus granti), during chemical 
immobilization with carfentanil-xylazine (CX), delivered by dart syringe from helicopter, during fall 2013 and 
spring 2014 in Alaska, USA. Mean ± SE (range) values are presented for all variables. *Significant difference 
after oxygen treatment. T1 is time from darting to collection of first sample. T2 is time from darting to second 
sample. 
   CX  CX  
   Before O2  After 10 min of O2  
Variable Unit N T1: 6 - 15 minutes N T2: 19 - 31 minutes P value 
Rectal temp C˚ 12 40.5±0.5 (39.7-41.2) 12 40.8±0.6 (40.0-41.8) 0.106 
Pulse Beat/min 9 52±8 (40-60) 9 50±15 (32-80) 0.301 
Respiratory rate Breaths/min 12 22±9 (8-40) 12 18±7 (8-28) 0.064 
pH  11 7.21±0.1 (6.99-7.40) 11 7.23±0.2 (6.98-7.56) 0.254 
PaCO2 mmHg 11 58.0±9.2 (42.8-69.1) 11 65.6±11.2 (41.3-80.9) 0.029* 
PaO2 mmHg 11 46±13 (33-74) 11 96±17 (60-115) <0.001* 
Lactate mmol/L 12 10.8±5.9 (1.1-19.5) 12 7.8±5.1 (1.3-16.6) <0.001* 
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Table 3. Physiological variables from free-ranging caribou (Rangifer tarandus granti), during chemical 
immobilization with thiafentanil-azaperone-xylazine (TAX), delivered by dart syringe from helicopter during 
fall 2013 and spring 2014 in Alaska, USA. Mean ± SE (range) values are presented for all variables. *Significant 
difference after oxygen treatment. T1 is time from darting to collection of first sample. T2 is time from darting to 
second sample. 
      TAX   TAX 
       Before O2   After 10 min of O2 
 Variable Unit N T1: 6 - 13 minutes N T2: 19 - 27 minutes P value 
Rectal temp C˚ 16 40.2±0.5 (39.0-40.8) 16 40.5±0.6 (39.4-41.4) <0.001* 
Pulse Beat/min 12 54±10 (40-68) 12 52±11 (28-66) 0.492 
Respiratory rate Breaths/min 10 17±10 (8 - 40) 10 15±7 (6 - 24) 0.317 
pH   14 7.25±0.07 (7.06-7.36) 14 7.28±0.08 (7.10-7.37) 0.024* 
PaCO2 mmHg 14 57.0±10.1 (35.8-73.1) 14 63.8±11.1 (52.9-83.3)  0.020* 
PaO2 mmHg 15 46±13 (24-74) 15 96±21 (61-132) <0.001* 
Lactate mmol/L 15 8.4±3.9 (2.1-15.5) 15 5.3±3.1 (1.5-11.4) <0.001* 
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Table 4. Drug doses and physiological variables collected from captive and free-ranging caribou (Rangifer tarandus granti), during chemical immobilization with 
thiafentanil-azaperone-medetomidine combinations. Caribou in a captive facility were hand injected (hi) or ground darted (d) in September 2013 and free-ranging caribou 
were darted from helicopter in October 2013, in Alaska, USA. Mean ± SE (range) values are presented for all variables. *Not temperature corrected values. 
Age, body 
weight kg Thiafentanil  Azaperone  Medetomidine 
Level 
immobilization Overall  
Flow 
rate Oxygen RR PaO2  PaCO2  lactate 
Captive mg (mg/kg) mg (mg/kg)  mg (mg/kg)   (1-5) 
 
 L/min 
 
brths/min  mmHg mmHg  mmol/L 
 
yearling, 91
hi
 2.73 (0.03) 
 
5 (0.055) 4 poor 2 Before O2 8 29 61.5 12.6 
       
With O2 4 144 94.2 10.6 
yearling, 89
hi
 1.46 (0.0164) 
 
4 (0.045) 3 excellent 1 Before O2 20 44 56 8.7 
       
With O2 10 131 66.4 3.6 
yearling, 95
hi
 1.6 (0.0168) 
 
4 (0.042) 3 good 1 BeforeO2 28 48 56.6 10.4 
       
With O2 28 82 65.8 5.6 
yearling, 87
hi
 1.6 (0.0183) 25 (0.29) 4 (0.046) 3 poor 1 Before O2 40 37 57.7 14.3 
       
With O2 N/R 53 92.9 7.9 
yearling, 82
hi
 1.5 (0.0183) 24.5 (0.29) 3.8 (0.046) 3 excellent 1 BeforeO2 N/R 38 60.2 10.4 
       
With O2 12 115 83.5 5 
adult, 109
d
 3.1 (0.028) 25 (0.23) 
 
2 poor 1 Before O2 28 52* 31.3* 4.2 
       
With O2 N/R 90* 24.2* 2.1 
adult, 100
d
 3 (0.03) 25 (0.25) 
 
2 poor 2 BeforeO2 16 61 53 7.7 
29 
 
       
With O2 24 N/R N/R N/R 
Free-ranging 
           5 months, 64
d
 1.5 (0.023) 25 (0.39) 5 (0.078) dead poor 
 
N/A 
    
       
N/A 
    5 months, N/R
d
 1.5 25 5 5 poor 
 
N/A 0 
   
       
N/A breathing 
   5 months, N/R
d
 1.5 25 2 4 poor 1 Before O2 2 52 46 5.5 
       
With O2 8 N/R N/R N/R 
5 months, 57
d
 1.5(0.026) 25 (0.44) 2 (0.035) 3 good 1 Before O2 30 34 64.9 16.8 
       
With O2 22 88 80.8 13.3 
5 months, N/R
d
 1.5 25 2 5 poor 1 Before O2 24 
   
       
With O2 0 
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FIGURE 1. Induction times for free-ranging caribou (Rangifer tarandus granti) calves 
immobilized with carfentanil-xylazine (CX) or thiafentanil-azaperone-xylazine (TAX) during 
fall 2013 and spring 2014 in Alaska, USA, were not significantly different (F1,38 = 1.46, P = 
0.23). 
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FIGURE 2. Recovery times were significantly (F1,38 = 14.49, P = <0.001) shorter for caribou 
(Rangifer tarandus granti) calves immobilized with thiafentanil-azaperone-xylazine (TAX) 
than with carfentanil-xylazine (CX), during fall 2013 and spring 2014 in Alaska, USA.  
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FIGURE 3. There was a significant increase in temperature during handling time for caribou 
(Rangifer tarandus granti) calves immobilized with thiafentanil-azaperone-xylazine (TAX) 
and carfentanil-xylazine (CX) during fall 2013 and spring 2014 in Alaska, USA.
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